PMID- 30738290 OWN - NLM STAT- MEDLINE DCOM- 20190705 LR - 20201209 IS - 1878-1705 (Electronic) IS - 1567-5769 (Linking) VI - 69 DP - 2019 Apr TI - Morphological and functional analysis of beige (Chediak-Higashi syndrome) mouse mast cells with giant granules. PG - 202-212 LID - S1567-5769(19)30119-5 [pii] LID - 10.1016/j.intimp.2019.01.053 [doi] AB - Chediak-Higashi syndrome is a rare autosomal recessive disease that causes hypopigmentation, recurrent infections, mild coagulation defects and neurological problems. Beige mice carry a mutation in the lysosome trafficking regulator (LYST) gene and display some of the key characteristics of human Chediak-Higashi syndrome, in particular, a high susceptibility to infection due to aberrant natural killer (NK) cell and polymorphonuclear leucocyte function. Morphological analysis of beige mice reveals the presence of enlarged lysosomes in a variety of cell types, including leucocytes, hepatocytes, fibroblasts and renal tubule cells. To examine the process of granule maturation and degranulation in beige mice mast cells, morphological studies have been conducted using a combination of electrophysiological techniques; however, few functional studies have been conducted with mast cells, such as mediator release. The aim of the present study was to determine the morphological and functional characteristics of skin and peritoneal mast cells and bone marrow-derived mast cells of homozygous (bg/bg) and heterozygous (bg/+) beige mice and wild-type (+/+) mice. The histamine concentration was lower in the peritoneal and bone marrow-derived mast cells of bg/bg mice compared with those of bg/+ and +/+ mice, but the histamine release response was potentiated. In vivo studies of passive cutaneous anaphylaxis showed no differences between bg/bg mice and either bg/+ or +/+ mice. Although bg/bg mast cells with enlarged granules display specific exocytotic processes in vitro, the consequences of mast cell activation in beige mice were similar to those of wild-type mice in vivo. CI - Copyright (c) 2019 Elsevier B.V. All rights reserved. FAU - Kiyoi, Takeshi AU - Kiyoi T AD - Division of Analytical Bio-medicine, Advanced Research Support Center, Ehime University, Shitsukawa, Toon, Ehime 791-0295, Japan; Department of Pharmacology, Ehime University Graduate School of Medicine Shitsukawa, Toon, Ehime 791-0295, Japan. FAU - Liu, Shuang AU - Liu S AD - Department of Pharmacology, Ehime University Graduate School of Medicine Shitsukawa, Toon, Ehime 791-0295, Japan. FAU - Sahid, Muhammad Novrizal Abdi AU - Sahid MNA AD - Department of Pharmacology, Ehime University Graduate School of Medicine Shitsukawa, Toon, Ehime 791-0295, Japan. FAU - Shudou, Masachika AU - Shudou M AD - Division of Analytical Bio-medicine, Advanced Research Support Center, Ehime University, Shitsukawa, Toon, Ehime 791-0295, Japan. FAU - Ogasawara, Masahito AU - Ogasawara M AD - Department of Pathogenesis and Control of Oral Diseases, Division of Dental Pharmacology, Iwate Medical University School of Dentistry, Morioka, Iwate 020-8505, Japan. FAU - Mogi, Masaki AU - Mogi M AD - Department of Pharmacology, Ehime University Graduate School of Medicine Shitsukawa, Toon, Ehime 791-0295, Japan. Electronic address: mmogi@m.ehime-u.ac.jp. FAU - Maeyama, Kazutaka AU - Maeyama K AD - Department of Pharmacology, Ehime University Graduate School of Medicine Shitsukawa, Toon, Ehime 791-0295, Japan. LA - eng PT - Journal Article DEP - 20190206 PL - Netherlands TA - Int Immunopharmacol JT - International immunopharmacology JID - 100965259 RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (Lyst protein, mouse) RN - 0 (Proteins) RN - 0 (Vesicular Transport Proteins) RN - 820484N8I3 (Histamine) SB - IM MH - Animals MH - Cell Degranulation MH - Cells, Cultured MH - Chediak-Higashi Syndrome/genetics/*immunology MH - Cytoplasmic Granules/*pathology MH - Disease Models, Animal MH - Histamine/metabolism MH - Homozygote MH - Humans MH - Intracellular Signaling Peptides and Proteins MH - Killer Cells, Natural/*immunology MH - Lysosomes/*pathology MH - Mast Cells/pathology/*physiology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Mutant Strains MH - Mutation/genetics MH - Neutrophils/*immunology MH - Proteins/genetics MH - Vesicular Transport Proteins EDAT- 2019/02/10 06:00 MHDA- 2019/07/06 06:00 CRDT- 2019/02/10 06:00 PHST- 2019/01/18 00:00 [received] PHST- 2019/01/30 00:00 [accepted] PHST- 2019/02/10 06:00 [pubmed] PHST- 2019/07/06 06:00 [medline] PHST- 2019/02/10 06:00 [entrez] AID - S1567-5769(19)30119-5 [pii] AID - 10.1016/j.intimp.2019.01.053 [doi] PST - ppublish SO - Int Immunopharmacol. 2019 Apr;69:202-212. doi: 10.1016/j.intimp.2019.01.053. Epub 2019 Feb 6.